These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62. Direct In Vivo Reprogramming with Sendai Virus Vectors Improves Cardiac Function after Myocardial Infarction. Miyamoto K; Akiyama M; Tamura F; Isomi M; Yamakawa H; Sadahiro T; Muraoka N; Kojima H; Haginiwa S; Kurotsu S; Tani H; Wang L; Qian L; Inoue M; Ide Y; Kurokawa J; Yamamoto T; Seki T; Aeba R; Yamagishi H; Fukuda K; Ieda M Cell Stem Cell; 2018 Jan; 22(1):91-103.e5. PubMed ID: 29276141 [TBL] [Abstract][Full Text] [Related]
63. Use of enhanced green fluorescent protein to optimize and quantitate infection of target cells with recombinant retroviruses. Cashion LM; Bare LA; Harvey S; Trinh Q; Zhu Y; Devlin JJ Biotechniques; 1999 May; 26(5):924-6, 928-30. PubMed ID: 10337486 [TBL] [Abstract][Full Text] [Related]
64. Postischemic administration of Sendai virus vector carrying neurotrophic factor genes prevents delayed neuronal death in gerbils. Shirakura M; Inoue M; Fujikawa S; Washizawa K; Komaba S; Maeda M; Watabe K; Yoshikawa Y; Hasegawa M Gene Ther; 2004 May; 11(9):784-90. PubMed ID: 14961067 [TBL] [Abstract][Full Text] [Related]
65. Significance of the YLDL motif in the M protein and Alix/AIP1 for Sendai virus budding in the context of virus infection. Irie T; Inoue M; Sakaguchi T Virology; 2010 Sep; 405(2):334-41. PubMed ID: 20605035 [TBL] [Abstract][Full Text] [Related]
66. Generation of human induced pluripotent stem cells from cord blood cells. Nishishita N; Takenaka C; Fusaki N; Kawamata S J Stem Cells; 2011; 6(3):101-8. PubMed ID: 23264996 [TBL] [Abstract][Full Text] [Related]
67. Cytoplasmic RNA vector derived from nontransmissible Sendai virus. Production and use. Iida A; Hasegawa M Methods Mol Med; 2002; 69():361-70. PubMed ID: 11987789 [No Abstract] [Full Text] [Related]
68. Alteration of Sendai virus morphogenesis and nucleocapsid incorporation due to mutation of cysteine residues of the matrix protein. Sakaguchi T; Uchiyama T; Huang C; Fukuhara N; Kiyotani K; Nagai Y; Yoshida T J Virol; 2002 Feb; 76(4):1682-90. PubMed ID: 11799163 [TBL] [Abstract][Full Text] [Related]
69. Contribution of the leader sequence to homologous viral interference among Sendai virus strains. Shimazu Y; Takao SI; Irie T; Kiyotani K; Yoshida T; Sakaguchi T Virology; 2008 Mar; 372(1):64-71. PubMed ID: 18035388 [TBL] [Abstract][Full Text] [Related]
70. Immunostimulatory virotherapy using recombinant Sendai virus as a new cancer therapeutic regimen. Yonemitsu Y; Ueda Y; Kinoh H; Hasegawa M Front Biosci; 2008 Jan; 13():1892-8. PubMed ID: 17981677 [TBL] [Abstract][Full Text] [Related]
71. Immunogenicity of repeated Sendai viral vector vaccination in macaques. Kurihara K; Takahara Y; Nomura T; Ishii H; Iwamoto N; Takahashi N; Inoue M; Iida A; Hara H; Shu T; Hasegawa M; Moriya C; Matano T Microbes Infect; 2012 Nov; 14(13):1169-76. PubMed ID: 22884717 [TBL] [Abstract][Full Text] [Related]
72. Ex vivo expansion of human HSCs with Sendai virus vector expressing HoxB4 assessed by sheep in utero transplantation. Abe T; Masuda S; Ban H; Hayashi S; Ueda Y; Inoue M; Hasegawa M; Nagao Y; Hanazono Y Exp Hematol; 2011 Jan; 39(1):47-54. PubMed ID: 20875838 [TBL] [Abstract][Full Text] [Related]
73. The effect of sequestration by nontarget tissues on anti-tumor efficacy of systemically applied, conditionally replicating adenovirus vectors. Bernt KM; Ni S; Gaggar A; Li ZY; Shayakhmetov DM; Lieber A Mol Ther; 2003 Nov; 8(5):746-55. PubMed ID: 14599807 [TBL] [Abstract][Full Text] [Related]
74. Development of an AIDS vaccine using Sendai virus vectors. Ishii H; Matano T Vaccine; 2015 Nov; 33(45):6061-5. PubMed ID: 26232346 [TBL] [Abstract][Full Text] [Related]
75. Rapid and efficient recovery of Sendai virus from cDNA: factors influencing recombinant virus rescue. Leyrer S; Neubert WJ; Sedlmeier R J Virol Methods; 1998 Nov; 75(1):47-58. PubMed ID: 9820574 [TBL] [Abstract][Full Text] [Related]
76. Nontransmissible virus-like particle formation by F-deficient sendai virus is temperature sensitive and reduced by mutations in M and HN proteins. Inoue M; Tokusumi Y; Ban H; Kanaya T; Tokusumi T; Nagai Y; Iida A; Hasegawa M J Virol; 2003 Mar; 77(5):3238-46. PubMed ID: 12584347 [TBL] [Abstract][Full Text] [Related]
77. Sendai virus recombinant vaccine expressing a secreted, unconstrained respiratory syncytial virus fusion protein protects against RSV in cotton rats. Zhan X; Slobod KS; Jones BG; Sealy RE; Takimoto T; Boyd K; Surman S; Russell CJ; Portner A; Hurwitz JL Int Immunol; 2015 May; 27(5):229-36. PubMed ID: 25477211 [TBL] [Abstract][Full Text] [Related]
78. Sendai Virus Induces Persistent Olfactory Dysfunction in a Murine Model of PVOD via Effects on Apoptosis, Cell Proliferation, and Response to Odorants. Tian J; Pinto JM; Cui X; Zhang H; Li L; Liu Y; Wu C; Wei Y PLoS One; 2016; 11(7):e0159033. PubMed ID: 27428110 [TBL] [Abstract][Full Text] [Related]
79. Epitope mapping of the nucleocapsid protein of sendai virus and application of antigenic epitopes for the ELISA-based diagnosis of sendai virus infection. Asano A; Torigoe D; Sasaki N; Agui T J Vet Med Sci; 2013 Jul; 75(7):909-16. PubMed ID: 23446107 [TBL] [Abstract][Full Text] [Related]
80. The YLDL sequence within Sendai virus M protein is critical for budding of virus-like particles and interacts with Alix/AIP1 independently of C protein. Irie T; Shimazu Y; Yoshida T; Sakaguchi T J Virol; 2007 Mar; 81(5):2263-73. PubMed ID: 17166905 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]